Immunotech Financial Statements From 2010 to 2025
| IMMB Stock | USD 0.0001 0.00 0.00% |
Check Immunotech Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immunotech Laboratories' main balance sheet or income statement drivers, such as , as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.0113. Immunotech financial statements analysis is a perfect complement when working with Immunotech Laboratories Valuation or Volatility modules.
Immunotech | Select Account or Indicator | Build AI portfolio with Immunotech Stock |
Financial Ratios | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immunotech Laboratories Valuation Data | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
About Immunotech Laboratories Financial Statements
Immunotech Laboratories stakeholders use historical fundamental indicators, such as Immunotech Laboratories' revenue or net income, to determine how well the company is positioned to perform in the future. Although Immunotech Laboratories investors may analyze each financial statement separately, they are all interrelated. For example, changes in Immunotech Laboratories' assets and liabilities are reflected in the revenues and expenses on Immunotech Laboratories' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Immunotech Laboratories. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Revenue Per Share | 9.09 | 8.08 | |
| Ebit Per Revenue | (24.94) | (26.18) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Immunotech Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Immunotech Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Immunotech Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Immunotech Laboratories Stock:Check out the analysis of Immunotech Laboratories Correlation against competitors. For information on how to trade Immunotech Stock refer to our How to Trade Immunotech Stock guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunotech Laboratories. If investors know Immunotech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunotech Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.30) |
The market value of Immunotech Laboratories is measured differently than its book value, which is the value of Immunotech that is recorded on the company's balance sheet. Investors also form their own opinion of Immunotech Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Immunotech Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunotech Laboratories' market value can be influenced by many factors that don't directly affect Immunotech Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunotech Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunotech Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunotech Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.